Cantel Medical Corp. CMD
— —
Day range unavailable
52-week range unavailable
Analyst view
Consensus: hold
Hold
Price target (mean) 62.00
Ratings (0m) 4 1 buy · 3 hold · 0 sell
- Strong buy1
- Buy0
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 4
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.60 | 0.48 – 0.74 | 0.16 | +275.0% | 293.21M | 0.0% | 4 |
| Next quarter | 0.70 | 0.62 – 0.78 | 0.24 | +191.7% | 307.95M | +32.0% | 2 |
| Current year | 2.99 | 2.78 – 3.20 | 1.65 | +81.2% | 1.19B | +17.5% | 2 |
| Next year | 3.20 | 2.90 – 3.50 | 2.99 | +7.0% | 1.28B | +7.6% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 13, 2021 | Needham | Downgrade | Buy | Hold |
| Aug 19, 2020 | B of A Securities | Initiated | — | Underperform |
| May 12, 2020 | Needham | Maintained | — | Buy |
| Apr 14, 2020 | Sidoti & Co. | Maintained | — | Buy |
| Feb 18, 2020 | Sidoti & Co. | Maintained | — | Buy |
| Feb 11, 2020 | Needham | Maintained | — | Buy |
| Nov 26, 2019 | Needham | Upgrade | Hold | Buy |
| Mar 1, 2019 | Raymond James | Downgrade | Outperform | Market Perform |
| Sep 28, 2018 | Sidoti & Co. | Maintained | Buy | Buy |
| Sep 28, 2018 | Raymond James | Maintained | Outperform | Outperform |
| Jan 3, 2018 | Raymond James | Upgrade | Market Perform | Outperform |
| Jun 9, 2017 | Benchmark | Downgrade | Buy | Hold |
| Mar 17, 2017 | Raymond James | Initiated | — | Market Perform |